GSE153158 NF-kB knockout U-937 1 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE153158_NF-kB knockout_U-937_1_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE153158_NF-kB knockout_U-937_1_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE153158_NF-kB knockout_U-937_1_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE153158_NF-kB knockout_U-937_1_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

uncharacterized LOC124905143

Gene

sorting nexin 25 pseudogene 1

Gene

OLA1 pseudogene 2

Gene

long intergenic non-protein coding RNA 1541

Gene

RNA, 7SL, cytoplasmic 784, pseudogene

Gene

TRPC6 pseudogene 10

Gene

tubulin beta 3 class III pseudogene 1

Gene

IQ motif containing M

Gene

gonadotropin releasing hormone receptor

Gene

phospholipid phosphatase related 2

  • Gene

    uncharacterized LOC124905143


  • Gene

    sorting nexin 25 pseudogene 1


  • Gene

    OLA1 pseudogene 2


  • Gene

    long intergenic non-protein coding RNA 1541


  • Gene

    RNA, 7SL, cytoplasmic 784, pseudogene


  • Gene

    TRPC6 pseudogene 10


  • Gene

    tubulin beta 3 class III pseudogene 1


  • Gene

    IQ motif containing M


  • Gene

    gonadotropin releasing hormone receptor


  • Gene

    phospholipid phosphatase related 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.